| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0004 |